Your browser doesn't support javascript.
loading
Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies.
Lebbé, C; Weber, J S; Maio, M; Neyns, B; Harmankaya, K; Hamid, O; O'Day, S J; Konto, C; Cykowski, L; McHenry, M B; Wolchok, J D.
Afiliação
  • Lebbé C; Department of Dermatology, APHP, CIC, U976 Hôpital Saint-Louis University Paris Diderot, Paris, France. Electronic address: celeste.lebbe@sls.aphp.fr.
  • Weber JS; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.
  • Maio M; Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy.
  • Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Harmankaya K; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Hamid O; Melanoma Therapeutics, Translational Research and Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles.
  • O'Day SJ; Los Angeles Skin Cancer Institute at Beverly Hills Cancer Center, Beverly Hills.
  • Konto C; Global Clinical Research.
  • Cykowski L; Global Clinical Research.
  • McHenry MB; Global Biometric Sciences, Bristol-Myers Squibb Company, Wallingford.
  • Wolchok JD; Ludwig Center for Cancer Immunotherapy, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
Ann Oncol ; 25(11): 2277-2284, 2014 Nov.
Article em En | MEDLINE | ID: mdl-25210016
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Imunoterapia / Melanoma / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Imunoterapia / Melanoma / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de publicação: Reino Unido